Cybin (NYSE:CYBN) CEO Doug Drysdale will join us to discuss their latest trials, where they reported a 71% remission rate in patients with major depressive disorder (MDD) for their leading compound, CYB003. We’ll ask what’s next regarding their Phase III trial and the performance of the psychedelic stock.
Plus, money is moving in the cannabis industry. Cory Azzalino, CEO of Eaze, will join us to highlight the company’s recent news about raising $10 million to acquire select assets of Eaze Technologies.
Finally, Adam Goers, SVP of Corporate Affairs at The Cannabist Company Holdings (OTC: CBSTF), will join us to share the latest he’s hearing from Washington and address any concerns about whether Matt Gaetz will still be appointed Attorney General, as announced last week by President-Elect Donald Trump.
#mattgaetz #donaldtrump #president #cannabis #cannabisindustry #cybin #psychedelicstocks
Want to see more earnings interviews?
• Trump, Gaetz, and Cannabis: A High-St...
Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!
https://newsletter.thedalesreport.com...
Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:
Facebook: / thedalesreport
Twitter: / thedalesreport
Instagram: / dalesreport
LinkedIn: / the-dales-report
Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...
Spotify: https://tinyurl.com/TDRTradeToBlackon...
Website: https://thedalesreport.com/
For copyright matters, please get in touch with us at:
sdales@thedalesreport.com
All views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have.
https://thedalesreport.com/website-te...
